Hi go seek, I feel similarly and I think tyzeka is a good drug and nm-283 down the road will find a place in the HCV arsenal..but I will admit, based on a very unclear regulatory path now for nm-283 and what looks like at least another couple quarters before tyzeka sales ramp up to anything meaningful, and lack of news expected until end of June, I did part with half my holdings (which is to say I still have a significant position!)
Market Data 
Markets 
AI
